background
osteonecrosi
known
one
disabl
complic
follow
corticosteroid
cs
medic
howev
evid
regard
risk
asymptomat
preval
among
differ
diseas
impact
variabl
steroid
regimen
conflict
aim
determin
preval
femor
head
asymptomat
patient
system
rheumat
diseas
receiv
highdos
cs
also
clarifi
relationship
differ
dosag
regimen
method
crosssect
studi
consecut
patient
receiv
highdos
cs
rheumat
diseas
pelvic
pain
recruit
mri
hip
perform
patient
use
tesla
diagnos
result
subject
develop
femor
head
group
without
compar
term
sex
age
mean
start
cs
dose
statist
differ
type
cs
regimen
includ
daili
dose
peak
dose
cumul
dose
two
group
howev
silent
associ
cumul
cs
dose
durat
cs
therapi
conclus
accord
high
preval
select
patient
identifi
risk
factor
monitor
high
risk
patient
period
hip
mri
would
help
diagnos
necrosi
earli
stage
kianmehr
n
bidari
mofidi
bahar
n
silent
osteonecrosi
femor
head
follow
highdos
corticosteroid
patient
system
rheumat
diseas
osteonecrosi
condit
character
bone
marrow
ischemia
cell
death
may
subsequ
lead
insuffici
fractur
secondari
osteoarthr
requir
palli
surgeri
although
femor
head
caus
variou
condit
trauma
alcohol
abus
hemoglobinopathi
cs
common
caus
nontraumat
earli
stage
patient
may
asymptomat
eventu
pain
limit
movement
may
develop
precis
impact
differ
regimen
cs
remain
matter
debat
literatur
studi
claim
independ
peak
daili
cumul
dose
cs
other
report
appear
associ
maximum
daili
dose
cs
crosssect
studi
conduct
extend
knowledg
preval
silent
among
patient
take
cs
associ
differ
cs
regimen
dosag
patient
recruit
rheumatolog
clinic
major
referr
teach
hospit
tehran
iran
consecut
enrol
rheumatolog
patient
receiv
highdos
cs
variou
condit
receiv
daili
equival
least
month
exclud
pain
limit
motion
hip
histori
hip
trauma
chronic
alcohol
abus
smoke
diabet
mellitu
hyperlipidemia
hyperuricemia
antiphospholipid
syndrom
hyperhomocysteinemia
presenc
v
leiden
factor
defici
protein
c
protein
antithromobin
iii
factor
ethic
aspect
studi
approv
univers
review
committe
inform
consent
obtain
patient
prior
particip
studi
structur
checklist
use
collect
data
demograph
variabl
dose
durat
cs
therapi
rout
cs
administr
complet
blood
count
lipid
panel
antiphospholipid
antibodi
hypercoagul
profil
measur
case
femor
head
target
screen
purpos
compris
frequent
site
csinduc
mri
studi
perform
singl
tesla
imag
scanner
report
independ
two
mri
expert
radiologist
third
one
case
disagr
defin
presenc
band
low
signal
intens
classic
imag
portion
femor
head
howev
radiologist
ask
report
abnorm
signal
intens
thereaft
patient
divid
nonon
group
base
mri
find
result
report
deviat
sd
quantit
variabl
percentag
categor
variabl
group
compar
use
student
ttest
continu
variabl
chisquar
test
categor
variabl
p
valu
less
consid
statist
signific
statist
analys
perform
use
spss
v
among
includ
patient
femal
male
age
year
rang
year
rheumatolog
diagnos
follow
takayasu
arter
case
microscop
polyangi
case
granulomatosi
polyangi
case
polymyos
case
tempor
arter
case
rheumatoid
arthriti
complic
scleritii
case
relaps
polychondr
case
adultonset
still
diseas
case
dermatomyos
case
system
lupu
erythematossi
case
diseas
case
occurr
correl
diseas
patient
p
durat
steroid
therapi
month
rang
month
start
cs
dose
mg
rang
mg
twenti
eight
patient
administ
high
cumul
dose
puls
cs
regimen
other
receiv
puls
regimen
found
patient
suffer
femor
neck
two
group
without
compar
term
sex
age
mean
start
highdos
cs
durat
highdos
cs
consumpt
longer
patient
p
moreov
signific
differ
type
steroid
regimen
nonon
group
total
cumul
cs
dose
relat
although
cumul
highdos
significantli
higher
patient
patient
without
p
among
studi
popul
cushingoid
face
appear
find
group
group
p
tabl
one
lifethreaten
disabl
complic
follow
long
term
cs
risk
period
develop
first
year
cs
treatment
also
major
caus
joint
replac
among
sle
patient
patient
current
studi
develop
studi
patient
sever
acut
respiratori
syndrom
sar
take
highdos
steroid
report
patient
anoth
studi
sle
patient
patient
develop
silent
five
patient
symptomat
studi
show
occurr
among
patient
multipl
sclerosi
studi
could
show
relationship
total
cumul
dose
puls
durat
steroid
treatment
kamata
et
al
report
patient
maximum
daili
dose
cs
significantli
higher
review
sle
patient
highdos
steroid
month
cumul
dose
consider
higher
patient
anoth
studi
sle
patient
mean
daili
dose
intraven
puls
addit
cumul
dose
prednisolon
relat
zhang
et
al
show
number
lesion
directli
associ
dosag
cs
puls
cumul
regimen
survey
sle
patient
follow
period
year
total
durat
cs
durat
treatment
relat
griffith
et
al
show
cumul
cs
dose
import
risk
factor
osteonecrosi
studi
preval
patient
take
less
g
one
receiv
studi
sekiya
et
al
correl
increas
dose
cs
higher
diseas
activ
among
sle
patient
survey
patient
reveal
high
dose
steroid
mgday
impos
remark
higher
risk
dose
differ
studi
popul
stage
silentsymptomat
might
caus
variabl
result
research
studi
suffer
limit
case
recruit
one
center
number
case
involv
suffici
evalu
relev
potenti
variabl
time
baselin
femor
head
mri
perform
exact
time
develop
unclear
case
addit
unabl
calcul
total
cumul
dose
cs
case
insuffici
data
hospit
file
rule
bia
natur
exclus
case
receiv
cs
sever
year
time
becom
symptomat
lose
chanc
includ
studi
defin
band
low
intens
hip
mri
though
definit
adopt
specif
highli
sensit
earli
search
mr
imag
subtl
evid
case
found
studi
radiologist
found
rel
high
rate
silent
group
patient
variou
rheumatolog
diseas
receiv
highdos
cs
present
studi
suggest
mri
hip
would
appropri
screen
higher
risk
silent
